Trolamine Salicylate: Difference between revisions

Trolamine Salicylate
	Adult Indications & Dosage
	Pediatric Indications & Dosage
	Contraindications
	Warnings & Precautions
	Adverse Reactions
	Drug Interactions
	Use in Specific Populations
	Administration & Monitoring
	Overdosage
	Pharmacology
	Clinical Studies
	How Supplied
	Images
	Patient Counseling Information
	Precautions with Alcohol
	Brand Names
	Look-Alike Names

VisualWikitext

Revision as of 16:05, 24 April 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Trolamine Salicylate is an analgesic that is FDA approved for the treatment of musculoskeletal pain and osteoarthritis. Common adverse reactions include erythema, skin irritation.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Indications

Temporarily relieves minor pain associated with:

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Trolamine Salicylate in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Trolamine Salicylate in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding FDA-Labeled Use of Trolamine Salicylate in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Trolamine Salicylate in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Trolamine Salicylate in pediatric patients.

Contraindications

There is limited information regarding Trolamine Salicylate Contraindications in the drug label.

Warnings

For external use only

Allergy alert: If prone to allergic reaction from aspirin or salicylates, consult a doctor before use.

When using this product

Use only as directed
Do not bandage tightly or use with a heating pad
Avoid contact with the eyes or mucous membranes
Do not apply to wounds or damaged skin
Stop use and ask a doctor if
Condition worsens
Symptoms persist for more than 7 days or clear up and occur again within a few days
Redness is present
Irritation develops
If pregnant or breast-feeding,
Ask a health professional before use.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Trolamine Salicylate in the drug label.

Body as a Whole

Cardiovascular

Digestive

Endocrine

Hematologic and Lymphatic

Metabolic and Nutritional

Musculoskeletal

Neurologic

Respiratory

Skin and Hypersensitivy Reactions

Special Senses

Urogenital

Miscellaneous

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Trolamine Salicylate in the drug label.

Body as a Whole

Cardiovascular

Digestive

Endocrine

Hematologic and Lymphatic

Metabolic and Nutritional

Musculoskeletal

Neurologic

Respiratory

Skin and Hypersensitivy Reactions

Special Senses

Urogenital

Miscellaneous

Drug Interactions

Drug

Description

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

Pregnancy Category

Pregnancy Category (AUS):

Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Trolamine Salicylate in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Trolamine Salicylate during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Trolamine Salicylate with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Trolamine Salicylate with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Trolamine Salicylate with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Trolamine Salicylate with respect to specific gender populations.

Race

There is no FDA guidance on the use of Trolamine Salicylate with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Trolamine Salicylate in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Trolamine Salicylate in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Trolamine Salicylate in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Trolamine Salicylate in patients who are immunocompromised.

Administration and Monitoring

Administration

Topical

Adults and children over 12 years:

Apply generously to affected area

Massage into painful area until thoroughly absorbed into skin

Repeat as necessary, but not more than 4 times daily

Monitoring

There is limited information regarding Monitoring of Trolamine Salicylate in the drug label

IV Compatibility

There is limited information regarding IV Compatibility of Trolamine Salicylate in the drug label.

Overdosage

There is limited information regarding Chronic Overdose of Trolamine Salicylate in the drug label.

Pharmacology

There is limited information regarding Trolamine Salicylate Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Trolamine Salicylate Mechanism of Action in the drug label.

Structure

There is limited information regarding Trolamine Salicylate Structure in the drug label.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Trolamine Salicylate in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Trolamine Salicylate in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Trolamine Salicylate in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Trolamine Salicylate in the drug label.

How Supplied

Storage

There is limited information regarding Trolamine Salicylate Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Trolamine Salicylate |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

This image is provided by the National Library of Medicine.

{{#ask: Label Page::Trolamine Salicylate |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Trolamine Salicylate in the drug label.

Precautions with Alcohol

Alcohol-Trolamine Salicylate interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

®^[1]

Look-Alike Drug Names

A® — B®^[2]

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

↑ Empty citation (help)
↑ "http://www.ismp.org". External link in |title= (help)

{{#subobject:

 |Page Name=Trolamine Salicylate
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject:

 |Label Page=Trolamine Salicylate
 |Label Name=Trolamine Salicylate11.png

}}

{{#subobject:

 |Label Page=Trolamine Salicylate
 |Label Name=Trolamine Salicylate11.png

}}

[1] Empty citation (help)

[www.ismp.org-2] "http://www.ismp.org". External link in |title= (help)

[1]

[2]

@@ Line 1: / Line 1: @@
 {{DrugProjectFormSinglePage
-|aOrAn=a
+|authorTag={{KS}}
+|genericName=trolamine salicylate
+|aOrAn=an
+|drugClass=analgesic
 |indicationType=treatment
-|hasBlackBoxWarning=Yes
+|indication=musculoskeletal pain and osteoarthritis
-|adverseReactions=<!--Black Box Warning-->
+|adverseReactions=erythema, skin irritation
 |blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span>
 |blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i>
@@ Line 12: / Line 15: @@
 <!--FDA-Labeled Indications and Dosage (Adult)-->
-|fdaLIADAdult======Condition1=====
+|fdaLIADAdult===Indications==
-* Dosing Information
+* Temporarily relieves minor pain associated with:
-:* Dosage
+:*[[Arthritis]]
+:*Simple [[backache]]
+:*[[Muscle strains]]
+:*[[Sprains]]
+:*[[Bruises]]
+|offLabelAdultGuideSupport=* There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
-=====Condition2=====
-* Dosing Information
+|offLabelAdultNoGuideSupport=* There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
-:* Dosage
-=====Condition3=====
-* Dosing Information
-:* Dosage
-=====Condition4=====
-* Dosing Information
-:* Dosage
-<!--Off-Label Use and Dosage (Adult)-->
-<!--Guideline-Supported Use (Adult)-->
-|offLabelAdultGuideSupport======Condition1=====
-* Developed by:
-* Class of Recommendation:
-* Strength of Evidence:
-* Dosing Information
-:* Dosage
-=====Condition2=====
-There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
-<!--Non–Guideline-Supported Use (Adult)-->
-|offLabelAdultNoGuideSupport======Condition1=====
-* Dosing Information
-:* Dosage
-=====Condition2=====
-There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
-<!--Pediatric Indications and Dosage-->
 <!--FDA-Labeled Indications and Dosage (Pediatric)-->
-|fdaLIADPed======Condition1=====
+|fdaLIADPed=* There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
-* Dosing Information
-:* Dosage
-=====Condition2=====
-There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
-<!--Off-Label Use and Dosage (Pediatric)-->
 <!--Guideline-Supported Use (Pediatric)-->
-|offLabelPedGuideSupport======Condition1=====
+|offLabelPedGuideSupport=* There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
-* Developed by:
-* Class of Recommendation:
-* Strength of Evidence:
-* Dosing Information
-:* Dosage
-=====Condition2=====
-There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
-<!--Non–Guideline-Supported Use (Pediatric)-->
-|offLabelPedNoGuideSupport======Condition1=====
-* Dosing Information
-:* Dosage
-=====Condition2=====
+|offLabelPedNoGuideSupport=* There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
-There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
-<!--Contraindications-->
+|warnings='''For external use only'''
-|contraindications=* Condition1
-<!--Warnings-->
+'''Allergy alert''': If prone to allergic reaction from aspirin or salicylates, consult a doctor before use.
-|warnings=* Description
-====Precautions====
+'''When using this product'''
-* Description
+:*Use only as directed
+:*Do not bandage tightly or use with a heating pad
+:*Avoid contact with the eyes or mucous membranes
+:*Do not apply to wounds or damaged skin
+:*Stop use and ask a doctor if
+:*Condition worsens
+:*Symptoms persist for more than 7 days or clear up and occur again within a few days
+:*Redness is present
+:*Irritation develops
+:*If pregnant or breast-feeding,
+:*Ask a health professional before use.
-<!--Adverse Reactions-->
+'''Keep out of reach of children'''.
-<!--Clinical Trials Experience-->
+:*If swallowed, get medical help or contact a Poison Control Center right away.
 |clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
@@ Line 264: / Line 206: @@
 <!--Administration and Monitoring-->
-|administration=* Oral
+|administration=* Topical
+'''Adults and children over 12 years''':
-* Intravenous
+* Apply generously to affected area
-|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
-* Description
+* Massage into painful area until thoroughly absorbed into skin
-<!--IV Compatibility-->
+* Repeat as necessary, but not more than 4 times daily
+|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label
 |IVCompat=There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
-<!--Overdosage-->
-|overdose====Acute Overdose===
-====Signs and Symptoms====
+|overdose=There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
+|structure=
-* Description
-====Management====
+|PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
-* Description
-===Chronic Overdose===
+|PK=There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.
-There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
-<!--Pharmacology-->
+|nonClinToxic=There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.
-<!--Drug box 2-->
-|drugBox=<!--Mechanism of Action-->
-|mechAction=*
-<!--Structure-->
+|clinicalStudies=There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.
-|structure=*
-: [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
-<!--Pharmacodynamics-->
+|howSupplied=*
-|PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
+|packLabel=[[File:Trolamine salicylate.jpg|thumb|none|600px|This image is provided by the National Library of Medicine.]]
-<!--Pharmacokinetics-->
+[[File:Trolamine salicylate ingredients and apperarance.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
-|PK=There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.
-<!--Nonclinical Toxicology-->
-|nonClinToxic=There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.
-<!--Clinical Studies-->
-|clinicalStudies=There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.
-<!--How Supplied-->
-|howSupplied=*
-|packLabel=<!--Patient Counseling Information-->
 |fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.